Our Providers

Jimmy Huebert, MD

Office Location(s)

Tulsa Bone & Joint Associates
4802 South 109th East Avenue
Tulsa, OK 74146
Location Phone: 918 392-1400

Speciality: Non-Surgical Spine Mgmt., Sport Medicine

EDUCATION

BOARD CERTIFICATIONS

Diplomate of the American Board of Internal Medicine

LICENSE

• Oregon - 2001
• Maryland - 2000
• Oklahoma - 1996

RESEARCH EXPERIENCE

1. Percutaneous Electrotherapeutic Stimulation Treatment for Osteoarthritis (PESTO, PESTO-II) University of Northern California
   
   
2. University of Maryland Medical Center: Effects of menstrual hormonal variations on the laxity of the ACL. Department of Physical Therapy, University of Maryland-Baltimore.
   
   
3. Elan Pharmaceuticals (Protocol # C98-022): A Phase IIIB, Long-Term, Open-Label, Multicenter Study to Assess the Safety and Tolerability of Intrathecally Administered Study Drug in Patients with Chronic Severe Pain.
   
   
4. Elan Pharmaceuticals (Protocol # C98-029): A Phase II, Multicenter, Open Label Safety and Feasibility Study designed to Administer a Continuous Epidural Infusion of the Study Drug in Patients with Severe Chronic Pain.
   
   
5. Allergan Inc. (Protocol # 191622-013): A Multicenter, Double-Blind, Randomized, Placebo Controlled, Parellel Group Clinical Study of the Safety and Efficacy of Botulinum Toxin Type A Purified Neurotoxin Complex Injections into areas of Focal Tenderness in Subjects with Chronic Low Back Pain.
   
   
6. Allergan, Inc.(Protocol # 9901B): A Double-Blind, Randomized, Clinical Study Comparing High, Moderate and Low Volume of Injectate per Trigger Point with Botulinum Toxin Type A in the Treatment of Cervical Myofascial Pain. (An Unrestricted Educational Grant)
   
   
7. Athena Neurosciences, Inc.; A Clinical Trial to Study Botulinum Toxin Type B in the Treatment of Low Back Myofascial Pain. (An Unrestricted Educational Grant)
   
   
8. SIMS Deltec (Protocol IDE #G980133): A Multi-Center, Clinical Study to Monitoring the Clinical Performance of an Intraspinal Low Profile Implantable Access System in Delivering Preservative Free Morphine into the Intrathecal Space in Patients with Chronic Pain of Malignant or Non-Malignant Origin.
   
   
9. Elan Pharmaceuticals (Protocol PETC #99-02C): A Prospective Open-Label, Sequential Dose Escalation Clinical Study Evaluating the Efficacy and Safety of Low Dose Versus High Dose Neurobloc in the Treatment of Lumbar and Gluteal Myofascial Pain.
   
   
10. Roxanne Laboratories (Protocol XSR-0100): A Double-Blind, Placebo-Controlled, Parallel-Group Comparison of the Safety and Efficacy of Two Dose Levels of XXX and Placebo in the Treatment of Osteoarthritis.
    
    
11. Anesta Corporation (Protocol AC 600/006): Evaluation of XXX Titration Practices in the Clinical Setting.
    
    
12. "Effects of Nitrates on Sex-Linked Lethal Mutation Rates in Drosophila Melanogaster."
    
    

PUBLICATIONS

Co-Author of "Botulinum Toxin Type A in the Treatment of Refractory Myofascial Pain".

Posterior Knee Pain in a High School Football Player. Abstract, MSSE 33(5)S233

ACADEMIC AFFILIATIONS

MEMBERSHIPS

• American Medical Society for Sports Medicine
• American College of Sports Medicine
• American Medical Association
• American College of Physicians-American Society of Internal Medicine
• American Pain Society
• International Spine Injection Society
• Oregon Medical Association
• Medical Society of Metropolitan Portland